Volume 63, Issue 5, Pages (May 2013)

Slides:



Advertisements
Similar presentations
The PSA Era is not Over for Prostate Cancer
Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Managing Cancer Pain: Basic Principles and Invasive Treatments
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Volume 61, Issue 6, Pages (June 2012)
Volume 199, Issue 4, Pages e235-e236 (April 2018)
Volume 73, Issue 1, Pages (January 2018)
Volume 61, Issue 5, Pages (May 2012)
Volume 53, Issue 5, Pages (May 2008)
Volume 50, Issue 5, Pages (November 2006)
Volume 53, Issue 5, Pages (May 2008)
Volume 66, Issue 6, Pages (December 2014)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Let the Games Begin (with EAU Approval)
Prostate Cancer Epidemic in Sight?
Volume 45, Issue 4, Pages (April 2004)
Volume 63, Issue 4, Pages (April 2013)
Volume 62, Issue 6, Pages (December 2012)
Volume 63, Issue 1, Pages (January 2013)
Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications  Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,
Volume 52, Issue 1, Pages (July 2007)
Bladder Cancer: A Major Public Health Issue
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 68, Issue 5, Pages (November 2015)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 51, Issue 1, Pages (January 2007)
Volume 61, Issue 4, Pages (April 2012)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Volume 74, Issue 1, Pages (July 2018)
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Volume 68, Issue 1, Pages (July 2015)
Volume 63, Issue 5, Pages (May 2013)
Volume 69, Issue 3, Pages (March 2016)
Volume 64, Issue 3, Pages (September 2013)
Volume 57, Issue 4, Pages e41-e42 (April 2010)
Counselling the Prostate Cancer Patient
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
The PSA Era is not Over for Prostate Cancer
Volume 71, Issue 6, Pages (June 2017)
Global Burden of Urologic Cancers, 1990–2013
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 6, Pages (June 2008)
Trends in Hypospadias Surgery: Results of a Worldwide Survey
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Economic Costs of Overactive Bladder in Germany
Volume 62, Issue 3, Pages (September 2012)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Testicular Cancer Variations in Time and Space in Europe
Volume 53, Issue 5, Pages (May 2008)
Prognostic Impact of Comorbidity in Patients with Bladder Cancer
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
New Trends in Managing the Prostate Cancer Patient
Economic Burden of Bladder Cancer Across the European Union
Volume 52, Issue 4, Pages (October 2007)
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Epidemiology and Demographics of Prostatitis
Volume 54, Issue 1, Pages (July 2008)
Managing Cancer Pain: Basic Principles and Invasive Treatments
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 63, Issue 5, Pages 823-829 (May 2013) Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base  Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, Jason A. Efstathiou, Chun Chieh Lin, Anthony L. Zietman, Katherine S. Virgo  European Urology  Volume 63, Issue 5, Pages 823-829 (May 2013) DOI: 10.1016/j.eururo.2012.11.015 Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 1 Distribution of primary therapies received by patients with muscle-invasive bladder cancer by age group. Aggressive therapies are shown in solid colors, nonaggressive therapies are shown in striped colors. European Urology 2013 63, 823-829DOI: (10.1016/j.eururo.2012.11.015) Copyright © 2012 European Association of Urology Terms and Conditions

Fig. 2 Chemotherapy use in patients with muscle-invasive bladder cancer by year of treatment. p for trend <0.001. European Urology 2013 63, 823-829DOI: (10.1016/j.eururo.2012.11.015) Copyright © 2012 European Association of Urology Terms and Conditions